-
公开(公告)号:US20200009048A1
公开(公告)日:2020-01-09
申请号:US16574766
申请日:2019-09-18
Applicant: NOFIMA AS
Inventor: Jurgen Schrezenmeir , Svein Halvor Knutsen , Simon Ballance
Abstract: Described herein is a sugar-depleted fruit or vegetable juice product, wherein said juice product is a fruit or vegetable juice or juice-retaining fruit or vegetable derived matter, wherein said juice product contains at least about 5 g/l gluconic acid and said juice product contains any two or three, of (i) at least about 0.5 g/l Ca2+, (ii) at least about 1 g/l K+, and (iii) at least about 0.1 g/l Mg2+. Also provided are methods of producing the same and the use thereof to assist in maintaining the health and well-being of a subject and in the treatment and prevention of medical ailments, specifically those associated with the over-consumption of glucose and/or sucrose or inappropriate metabolism of glucose, e.g. metabolic syndrome, diabetes mellitus type II, obesity, dyslipidemia, insulin resistance, hypertension and liver steatosis.
-
公开(公告)号:US10786452B2
公开(公告)日:2020-09-29
申请号:US16574766
申请日:2019-09-18
Applicant: NOFIMA AS
Inventor: Jurgen Schrezenmeir , Svein Halvor Knutsen , Simon Ballance
Abstract: Described herein is a sugar-depleted fruit or vegetable juice product, wherein said juice product is a fruit or vegetable juice or juice-retaining fruit or vegetable derived matter, wherein said juice product contains at least about 5 g/l gluconic acid and said juice product contains any two or three, of (i) at least about 0.5 g/l Ca2+, (ii) at least about 1 g/l K+, and (iii) at least about 0.1 g/l Mg2+. Also provided are methods of producing the same and the use thereof to assist in maintaining the health and well-being of a subject and in the treatment and prevention of medical ailments, specifically those associated with the over-consumption of glucose and/or sucrose or inappropriate metabolism of glucose, e.g. metabolic syndrome, diabetes mellitus type II, obesity, dyslipidemia, insulin resistance, hypertension and liver steatosis.
-
公开(公告)号:US10471009B2
公开(公告)日:2019-11-12
申请号:US15515883
申请日:2015-10-01
Applicant: NOFIMA AS
Inventor: Jurgen Schrezenmeir , Svein Halvor Knutsen , Simon Ballance
Abstract: The present invention provides a sugar-depleted fruit or vegetable juice product, wherein said juice product is a fruit or vegetable juice or juice-retaining fruit or vegetable derived matter, wherein said juice product contains at least about 5 g/l gluconic acid and said juice product contains any two or three, of (i) at least about 0.5 g/l Ca2+, (iii) at least about 1 g/l K+, and (iii) at least about 0.1 g/l Mg2+. Also provided are methods of producing the same and the use thereof to assist in maintaining the health and well-being of a subject and in the treatment and prevention of medical ailments, specifically those associated with the over-consumption of glucose and/or sucrose or inappropriate metabolism of glucose, e.g. metabolic syndrome, diabetes mellitus type II, obesity, dyslipidemia, insulin resistance, hypertension and liver steatosis.
-
公开(公告)号:US20170296468A1
公开(公告)日:2017-10-19
申请号:US15515883
申请日:2015-10-01
Applicant: NOFIMA AS
Inventor: Jurgen Schrezenmeir , Svein Halvor Knutsen , Simon Ballance
CPC classification number: A61K9/0095 , A23L2/52 , A23L2/84 , A23L33/30 , A23V2002/00 , A61K31/191 , A61K33/00 , A61K33/06 , A23V2200/306 , A23V2200/322 , A23V2200/3322 , A23V2250/04 , A23V2250/1578 , A23V2250/161 , A61K2300/00
Abstract: The present invention provides a sugar-depleted fruit or vegetable juice product, wherein said juice product is a fruit or vegetable juice or juice-retaining fruit or vegetable derived matter, wherein said juice product contains at least about 5 g/l gluconic acid and said juice product contains any two or three, of (i) at least about 0.5 g/l Ca2+, (iii) at least about 1 g/l K+, and (iii) at least about 0.1 g/l Mg2+. Also provided are methods of producing the same and the use thereof to assist in maintaining the health and well-being of a subject and in the treatment and prevention of medical ailments, specifically those associated with the over-consumption of glucose and/or sucrose or inappropriate metabolism of glucose, e.g. metabolic syndrome, diabetes mellitus type II, obesity, dyslipidemia, insulin resistance, hypertension and liver steatosis.
-
-
-